These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22553321)

  • 41. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
    Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
    Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of CD8+ T-cell response in HIV infection.
    Benito JM; López M; Soriano V
    AIDS Rev; 2004; 6(2):79-88. PubMed ID: 15332430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibody.
    Peut V; Kent SJ
    Curr HIV Res; 2006 Apr; 4(2):191-7. PubMed ID: 16611057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
    Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
    J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of viral evolution and CTL responses in HIV-1 infection.
    Liu Y; McNevin JP; Holte S; McElrath MJ; Mullins JI
    PLoS One; 2011 Jan; 6(1):e15639. PubMed ID: 21283794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
    Liu Y; Mullins JI; Mittler JE
    Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.
    Fujiwara M; Tanuma J; Koizumi H; Kawashima Y; Honda K; Mastuoka-Aizawa S; Dohki S; Oka S; Takiguchi M
    J Virol; 2008 Jan; 82(1):138-47. PubMed ID: 17959671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
    Cao J; McNevin J; McSweyn M; Liu Y; Mullins JI; McElrath MJ
    J Virol; 2008 Jan; 82(1):495-502. PubMed ID: 17942528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying the impact of human immunodeficiency virus-1 escape from cytotoxic T-lymphocytes.
    Kadolsky UD; Asquith B
    PLoS Comput Biol; 2010 Nov; 6(11):e1000981. PubMed ID: 21079675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
    J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 epitopes presented by MHC class I types associated with superior immune containment of viremia have highly constrained fitness landscapes.
    Gorin AM; Du Y; Liu FY; Zhang TH; Ng HL; Hofmann C; Cumberland WG; Sun R; Yang OO
    PLoS Pathog; 2017 Aug; 13(8):e1006541. PubMed ID: 28787455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
    Feeney ME; Tang Y; Roosevelt KA; Leslie AJ; McIntosh K; Karthas N; Walker BD; Goulder PJ
    J Virol; 2004 Aug; 78(16):8927-30. PubMed ID: 15280502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
    Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
    Ganusov VV
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution and transmission of stable CTL escape mutations in HIV infection.
    Goulder PJ; Brander C; Tang Y; Tremblay C; Colbert RA; Addo MM; Rosenberg ES; Nguyen T; Allen R; Trocha A; Altfeld M; He S; Bunce M; Funkhouser R; Pelton SI; Burchett SK; McIntosh K; Korber BT; Walker BD
    Nature; 2001 Jul; 412(6844):334-8. PubMed ID: 11460164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.